000 01864 a2200517 4500
005 20250515223126.0
264 0 _c20100816
008 201008s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/1471-2407-10-185
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSteffensen, Karina Dahl
245 0 0 _aLack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer.
_h[electronic resource]
260 _bBMC cancer
_cMay 2010
300 _a185 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCA-125 Antigen
_xblood
650 0 4 _aCarboplatin
_xadministration & dosage
650 0 4 _aCarcinoma
_xchemistry
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aGynecologic Surgical Procedures
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aMembrane Proteins
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aOvarian Neoplasms
_xchemistry
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSecond-Look Surgery
650 0 4 _aTime Factors
650 0 4 _aTissue Array Analysis
_xmethods
650 0 4 _aTissue Inhibitor of Metalloproteinase-1
_xanalysis
650 0 4 _aTreatment Outcome
700 1 _aWaldstrøm, Marianne
700 1 _aChristensen, Rikke Kølby
700 1 _aBartels, Annette
700 1 _aBrünner, Nils
700 1 _aJakobsen, Anders
773 0 _tBMC cancer
_gvol. 10
_gp. 185
856 4 0 _uhttps://doi.org/10.1186/1471-2407-10-185
_zAvailable from publisher's website
999 _c19814569
_d19814569